Thermopylae Holdings Ltd.

Thermopylae Holdings (10% owner) purchases 38,000 shares of ABCL at $3.44; prior ABCL buys show 100% 90-day win rate.

Thermopylae Holdings, a 10% shareholder, acquired 38,000 shares at $3.44 on 2026-02-27, extending its stake to 56.13M shares. This transaction is part of a consistent buying pattern at ABCL: the insider's two prior measurable trades at this ticker (2025-03-11 and 2024-08-29) both delivered positive 90-day returns (+16.2% and +14.9%, respectively), a 100% timing success rate over the evaluated window. The current price of $3.82 sits -38.1% from the 52-week high but +5.5% over 30 days, indicating recovery momentum in a stock that remains distressed. AbCellera's fundamentals show severe unprofitability (net income of -$57.1M on revenue of $9.0M in the latest quarter), but management is executing aggressive growth (annual revenue growth of +160.6%), a tension that may explain the stock's volatility. The 10% holder's repeat accumulation at similar price levels—and the prior success of such purchases—suggests confidence in the recovery trajectory despite current losses.

Thermopylae Holdings (10% owner) bought 177,457 shares of ABCL at $3.27; stock now at $3.61, down 41.5% from 52-week high.

Thermopylae Holdings, already holding 56.10M shares (10% ownership), purchased an additional 177,457 shares at $3.27, adding 0.3% to its position. At the filing date the stock traded at $3.61, showing -7.4% over 30 days and -3.2% over 90 days, despite the company's revenue growing 160.6% year-over-year. The insider's same-ticker history at ABCL shows 2 of 2 prior buys achieved positive 90-day returns (+16.2% in March 2025 and +14.9% in August 2024), establishing a pattern of opportunistic buying ahead of recoveries. However, current valuation pressures—reflected in the -41.5% distance from the 52-week high and the company's unprofitable status ($-57.1M net income on $9.0M quarterly revenue)—suggest the insider is purchasing during a sustained period of underperformance despite strong topline growth. The continued accumulation by a 10% owner during a downturn warrants attention to whether this reflects confidence in the company's path to profitability or mechanical rebalancing given the position's significance.

10% owner Thermopylae Holdings acquires 343,631 shares of ABCL at $2.16 amid 55% drawdown from 52-week high.

Thermopylae Holdings, a 10% shareholder in AbCellera, purchased 343,631 shares at $2.16 on 2025-03-11, increasing its stake to 56,143,640 shares. The transaction occurs against a backdrop of material weakness: ABCL is currently trading at $2.23, down 55.0% from its 52-week high of $4.96, and has declined 28.1% over the past 30 days and 23.4% over 90 days. AbCellera faces fundamental headwinds with annual revenue growth of -24.2% and net income of -$51,107,000.00, indicating sustained operating losses. Thermopylae's prior purchase at this ticker (2024-08-29) also resulted in a +14.9% 90-day return, consistent with its cross-ticker track record of 100% win-rate timing on buys, though the current stock action—sharp declines in recent periods—contrasts with the insider's historical success pattern at ABCL.

Thermopylae Holdings (10% owner) purchased 283,516 shares of ABCL at $2.61; stock now at $2.53, down -57.6% from 52-week high.

Thermopylae Holdings, which owns 56,086,009 shares post-transaction (approximately 10% of the company), purchased an additional 283,516 shares at $2.61 on 2024-08-29 for $739,976.76 total value. The transaction occurred amid significant deterioration in the company's fundamentals and price trajectory: AbCellera reported revenue of $7,323,000.00 in its latest quarter with net income of $-36,930,000.00, and annual revenue growth contracted by -92.2% year-over-year. The stock has declined -21.7% over 30 days and -35.5% over 90 days, trading at $2.53 today, -57.6% below its 52-week high of $5.97. This purchase by a major shareholder occurs within a context of sustained operational and financial contraction, with the company unprofitable over its most recent full fiscal year.